Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 390

1.

Endogenous sex hormones and prostate cancer risk: a case-control study nested within the Carotene and Retinol Efficacy Trial.

Chen C, Weiss NS, Stanczyk FZ, Lewis SK, DiTommaso D, Etzioni R, Barnett MJ, Goodman GE.

Cancer Epidemiol Biomarkers Prev. 2003 Dec;12(12):1410-6.

2.

Prospective study of sex hormone levels and risk of prostate cancer.

Gann PH, Hennekens CH, Ma J, Longcope C, Stampfer MJ.

J Natl Cancer Inst. 1996 Aug 21;88(16):1118-26.

PMID:
8757191
3.

Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era.

Platz EA, Leitzmann MF, Rifai N, Kantoff PW, Chen YC, Stampfer MJ, Willett WC, Giovannucci E.

Cancer Epidemiol Biomarkers Prev. 2005 May;14(5):1262-9.

4.

Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC).

Kaaks R, Berrino F, Key T, Rinaldi S, Dossus L, Biessy C, Secreto G, Amiano P, Bingham S, Boeing H, Bueno de Mesquita HB, Chang-Claude J, Clavel-Chapelon F, Fournier A, van Gils CH, Gonzalez CA, Gurrea AB, Critselis E, Khaw KT, Krogh V, Lahmann PH, Nagel G, Olsen A, Onland-Moret NC, Overvad K, Palli D, Panico S, Peeters P, Quirós JR, Roddam A, Thiebaut A, Tjønneland A, Chirlaque MD, Trichopoulou A, Trichopoulos D, Tumino R, Vineis P, Norat T, Ferrari P, Slimani N, Riboli E.

J Natl Cancer Inst. 2005 May 18;97(10):755-65.

PMID:
15900045
5.

Circulating steroid hormones and the risk of prostate cancer.

Severi G, Morris HA, MacInnis RJ, English DR, Tilley W, Hopper JL, Boyle P, Giles GG.

Cancer Epidemiol Biomarkers Prev. 2006 Jan;15(1):86-91.

6.

Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones.

Tworoger SS, Missmer SA, Barbieri RL, Willett WC, Colditz GA, Hankinson SE.

J Natl Cancer Inst. 2005 Apr 20;97(8):595-602.

PMID:
15840882
7.

Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.

Eliassen AH, Missmer SA, Tworoger SS, Spiegelman D, Barbieri RL, Dowsett M, Hankinson SE.

J Natl Cancer Inst. 2006 Oct 4;98(19):1406-15.

PMID:
17018787
8.

Vasectomy and prostate cancer: results from a multiethnic case-control study.

John EM, Whittemore AS, Wu AH, Kolonel LN, Hislop TG, Howe GR, West DW, Hankin J, Dreon DM, Teh CZ, et al.

J Natl Cancer Inst. 1995 May 3;87(9):662-9.

PMID:
7538594
9.

Case-control study of endogenous steroid hormones and endometrial cancer.

Potischman N, Hoover RN, Brinton LA, Siiteri P, Dorgan JF, Swanson CA, Berman ML, Mortel R, Twiggs LB, Barrett RJ, Wilbanks GD, Persky V, Lurain JR.

J Natl Cancer Inst. 1996 Aug 21;88(16):1127-35.

PMID:
8757192
10.
11.

Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis.

Gann PH, Ma J, Giovannucci E, Willett W, Sacks FM, Hennekens CH, Stampfer MJ.

Cancer Res. 1999 Mar 15;59(6):1225-30.

12.

V89L polymorphism of the 5alpha-reductase Type II gene (SRD5A2), endogenous sex hormones, and prostate cancer risk.

Boger-Megiddo I, Weiss NS, Barnett MJ, Goodman GE, Chen C.

Cancer Epidemiol Biomarkers Prev. 2008 Feb;17(2):286-91. doi: 10.1158/1055-9965.EPI-07-0238.

13.

Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1).

Beattie MS, Costantino JP, Cummings SR, Wickerham DL, Vogel VG, Dowsett M, Folkerd EJ, Willett WC, Wolmark N, Hankinson SE.

J Natl Cancer Inst. 2006 Jan 18;98(2):110-5.

PMID:
16418513
14.

Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.

Missmer SA, Eliassen AH, Barbieri RL, Hankinson SE.

J Natl Cancer Inst. 2004 Dec 15;96(24):1856-65.

PMID:
15601642
15.

Plasma testosterone and sex hormone-binding globulin concentrations and the risk of prostate cancer among Japanese men: a nested case-control study.

Sawada N, Iwasaki M, Inoue M, Sasazuki S, Yamaji T, Shimazu T, Tsugane S; Japan Public Health Center-based Prospective Study Group.

Cancer Sci. 2010 Dec;101(12):2652-7. doi: 10.1111/j.1349-7006.2010.01721.x. Epub 2010 Sep 8.

16.

Effects of long-term alpha-tocopherol supplementation on serum hormones in older men.

Hartman TJ, Dorgan JF, Woodson K, Virtamo J, Tangrea JA, Heinonen OP, Taylor PR, Barrett MJ, Albanes D.

Prostate. 2001 Jan 1;46(1):33-8.

PMID:
11170129
17.

Serum lycopene, other carotenoids, and prostate cancer risk: a nested case-control study in the prostate, lung, colorectal, and ovarian cancer screening trial.

Peters U, Leitzmann MF, Chatterjee N, Wang Y, Albanes D, Gelmann EP, Friesen MD, Riboli E, Hayes RB.

Cancer Epidemiol Biomarkers Prev. 2007 May;16(5):962-8.

18.

Serum sex hormone levels are related to breast cancer risk in postmenopausal women.

Dorgan JF, Longcope C, Stephenson HE Jr, Falk RT, Miller R, Franz C, Kahle L, Campbell WS, Tangrea JA, Schatzkin A.

Environ Health Perspect. 1997 Apr;105 Suppl 3:583-5.

19.

Relation of serum levels of testosterone and dehydroepiandrosterone sulfate to risk of breast cancer in postmenopausal women.

Zeleniuch-Jacquotte A, Bruning PF, Bonfrer JM, Koenig KL, Shore RE, Kim MY, Pasternack BS, Toniolo P.

Am J Epidemiol. 1997 Jun 1;145(11):1030-8.

PMID:
9169912
20.

Relation of prediagnostic serum estrogen and androgen levels to breast cancer risk.

Dorgan JF, Longcope C, Stephenson HE Jr, Falk RT, Miller R, Franz C, Kahle L, Campbell WS, Tangrea JA, Schatzkin A.

Cancer Epidemiol Biomarkers Prev. 1996 Jul;5(7):533-9.

Supplemental Content

Support Center